CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024
15. Juli 2024 16:30 ET
|
CVRx, Inc.
MINNEAPOLIS, July 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer
25. Juni 2024 06:50 ET
|
CVRx, Inc.
MINNEAPOLIS, June 25, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced the appointment of Robert John as Chief Revenue Officer...
CVRx to Present at the William Blair 44th Annual Growth Stock Conference
22. Mai 2024 08:30 ET
|
CVRx, Inc.
MINNEAPOLIS, May 22, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the William...
CVRx Announces Key Senior Leadership Team Hires
16. Mai 2024 07:30 ET
|
CVRx, Inc.
Dr. Philip B. Adamson will join as Chief Medical OfficerBonnie Handke will join as Senior Vice President of Patient Access, Reimbursement, and Healthcare EconomicsJennifer E. Englund joins as Senior...
CVRx Reports First Quarter 2024 Financial and Operating Results
30. April 2024 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024
16. April 2024 16:30 ET
|
CVRx, Inc.
MINNEAPOLIS, April 16, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
CVRx announces availability of additional data supporting long-term benefits of Barostim
15. April 2024 07:30 ET
|
CVRx, Inc.
BeAT-HF trial data published in the European Journal of Heart Failure and new abstracts presented at THT conference MINNEAPOLIS, Minn., April 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX)...
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer
31. Januar 2024 08:00 ET
|
CVRx, Inc.
Appointment effective February 12 following Nadim Yared’s retirement Hykes currently serves as Augmedics’ President and CEO, and has served on CVRx’s Board of Directors since 2022 MINNEAPOLIS, Jan. ...
CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
25. Januar 2024 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024
11. Januar 2024 16:30 ET
|
CVRx, Inc.
MINNEAPOLIS, Jan. 11, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...